Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Perlegen expands leadership team
November 2007
SHARING OPTIONS:

MOUNTAIN VIEW, Calif.—Perlegen Sciences recently announced the addition of three senior professionals to help the company prepare for several key landmark drug response studies. Joining the company's senior operations team are Ellen M. Beasley, Ph.D., Keith Joho, Ph.D. and Jeff Otto, Ph.D.
"With the addition of these key executives, Perlegen's operating team has transitioned to a fully matrixed organization, quickly and efficiently delivering genotype information, production sequencing and genetic analyses aimed at uncovering the important genetic drivers behind variable drug response in a variety of key clinical situations," says Perlegen CEO Bryan Walser, M.D.
 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.